Our
Clients
: Aug, 2020
: 100
:
Global Digital Pathology Market Analysis by Product, Type, Application, End Users, and Region and segments forecast till 2033
Market Overview
The global Digital Pathology Market was worth USD 878.96 million in 2022 and is anticipated to amplify at a CAGR of 9.3% over 2023-2033, thereby accumulating USD 1,790.33 million by end of the analysis timeline.
Digital pathology generally refers to a dynamic, image-based environment that has enabled the acquisition, management, and also interpretation of pathology information which is generated from a digitalized glass slide. Digital pathology is mainly gaining momentum as an essential technology and have specific support for education, tissue based research, drug development, and also the practice of human pathology throughout the world. Digital pathology is important because it helps in reducing human error and producing precise diagnostic results in short period of time. Also, digital pathology helps in to speed up routine tasks.
Digital pathology technology is aiding a research pipeline in two ways. The first one is the specified file storage and viewing applications that can be used to arrange macroscopic images, tissue microarrays, and entire slide images. The second application of digital pathology in research is the development and implementation of image analysis techniques. Growth of the global digital pathology market is majorly driven by rising prevalence of cancer, also rising demand for accurate diagnostics, and development of new digital pathology system by a large number of key players. Also, the prevalence of chronic and cardiovascular diseases and the need for digital pathology system that is increasing has driven the growth of the digital pathology market.
One of the major driving factors of the global digital pathology market is the rise in generic and rapid technological advancements in digital pathology system. This factor has boosted Digital Pathology Market growth over the forecast duration. Also, the rise in number of cancer cases is another factor that is increasing Digital Pathology Market growth. The rise in chronic and cardiovascular diseases acts as another factor boosting Digital Pathology Market growth. The use of Artificial Intelligence (AI) has also proven to be more effective than previous techniques used in identifying and evaluating pathological characteristics. The implementation of AI has helped in accelerating and strengthening diagnosis and also in making the process of drug discovery more successful and cost-efficient. This has boosted the digital pathology market over the forecast year.
It is also seen that digital pathology has played an important role in companion diagnostics and drug development pipelines that includes molecular biology, bio banking, molecular tissue profiling, and tissue microarray analysis. The increase in demand for high-quality tissue samples in tissue-based biomarker research is projected to propel the adoption of Digital Pathology Market over the forecast period.
Report Scope
Report Attributes | Description |
Market Size in 2022 | USD 878.96 Million |
Market Forecast in 2033 | USD 1,790.33 Million |
CAGR % 2023-2033 | 9.3% |
Base Year | 2022 |
Historic Data | 2020-2021 |
Forecast Period | 2023-2033 |
Report USP | Production, Consumption, company share, company heatmap, company production capacity, growth factors and more |
Segments Covered | Product, Type, Application, and End Users |
Regional Scope | North America, Europe, APAC, South America and Middle East and Africa |
Country Scope | U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Key Companies | BiosystemsBiosystems, Leica Biosystems, Koninklijke Philips N.V., Hamamatsu Photonics, F. Hoffmann-La Roche Ltd., 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Inc, Huron Digital Pathology, Visiopharm A/S, Aiforia Technologies Oy, Akoya Biosciences, Corista, Indica Labs, Objective Pathology Services, Sectra AB, OptraSCAN, Glencoe Software, KONFOONG BIOTECH INTERNATIONAL CO., LTD, Inspirata, Inc., PathAI, Proscia Inc., Kanteron Systems, Mikroscan Technologies,Motic, Paige and Others. |
Impact of COVID
The COVID-19 pandemic has had a significant impact on the Digital Pathology market, mainly due to the increased demand for digital pathology solutions to support remote diagnosis and consultations. With lockdowns and social distancing measures in place, there has been a growing need for remote access to diagnostic tools, which has led to a surge in demand for digital pathology solutions. This has driven the adoption of digital pathology solutions across the world, particularly in countries where there are shortages of pathologists and medical experts. Additionally, the pandemic has also led to the adoption of digital pathology solutions for COVID-19 diagnosis and research.
Product Insights
The scanner segment has dominated the digital pathology market over the recent years. This is because of the increase in R&D activities in pharmaceutical & medical device industry, rising demand for diagnosis of diseases, and a rise in adoption of digital pathology systems.
Type Insights
Human pathology is growing in the digital pathology market due to several reasons. Firstly, digital pathology provides a more efficient and accurate method of analyzing and diagnosing pathology specimens compared to traditional microscopy-based methods. This is particularly important in human pathology, where the accuracy of diagnosis is critical for patient outcomes. Secondly, digital pathology enables remote consultation and collaboration among pathologists, which is especially beneficial for rare or complex cases that require specialized expertise. This helps to reduce diagnostic errors and improve patient outcomes. Finally, the increasing prevalence of chronic diseases such as cancer and the growing demand for personalized medicine are driving the need for advanced diagnostic tools, including digital pathology. The ability of digital pathology to generate large amounts of data and facilitate data analysis is also contributing to its growth in human pathology.
Application Insights
Teleconsultation is growing in the digital pathology market due to several reasons. Firstly, teleconsultation enables remote access to pathology images and reports, allowing pathologists to review cases and provide consultations from anywhere in the world. This results in reduced turnaround time and faster diagnosis for patients. Secondly, teleconsultation allows for collaboration between pathologists, enabling them to share expertise and knowledge to improve the accuracy of diagnoses. This is particularly useful in rare or complex cases where multiple opinions may be required. Thirdly, the COVID-19 pandemic has accelerated the adoption of teleconsultation in pathology, as it reduces the need for in-person consultations and minimizes the risk of infection transmission. Overall, teleconsultation provides several benefits such as improved efficiency, accuracy, and accessibility, driving its growth in the digital pathology market.
End Users Insights
The Clinical segment is growing in the Digital Pathology Market due to several factors. One of the main drivers of growth in this segment is the increasing use of digital pathology technology for diagnosis, research, and education in clinical settings. Digital pathology allows for faster and more accurate diagnosis of diseases, as well as the ability to share images and data among healthcare professionals in real-time, leading to improved patient outcomes.
Regional Insights
The Global Digital Pathology Market is further segmented into five major countries- North America, Europe, Asia-pacific, Latin Americ and Middle East and Africa
North America has dominated the digital pathology market, worldwide. This is because of the rising number of various types of cancer cases, and also presence of key players, as well as development of the healthcare sector.
Competitive Analysis
Key players operating in the worldwide Digital Pathology Market are BiosystemsBiosystems, Leica Biosystems, Koninklijke Philips N.V., Hamamatsu Photonics, F. Hoffmann-La Roche Ltd., 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Inc, Huron Digital Pathology, Visiopharm A/S, Aiforia Technologies Oy, Akoya Biosciences, Corista, Indica Labs, Objective Pathology Services, Sectra AB, OptraSCAN, Glencoe Software, KONFOONG BIOTECH INTERNATIONAL CO., LTD, Inspirata, Inc., PathAI, Proscia Inc., Kanteron Systems, Mikroscan Technologies,Motic, Paige and Others.
Recent News
In March 2022, Fimmic, a Finnish provider of digital pathology solutions, announced that it had raised 4.6 million ($5.2 million) in funding to expand its platform, which uses artificial intelligence (AI) to assist pathologists in analyzing tissue samples.
In February 2022, Inspirata, a leading provider of digital pathology and cancer informatics solutions, announced that it had acquired Omnyx, a provider of digital pathology workflow software. The acquisition is expected to enhance Inspirata's digital pathology platform and enable the company to offer end-to-end pathology workflow solutions.
In January 2022, Philips announced the launch of its new IntelliSite Pathology Solution 10 platform, which features enhanced AI capabilities and workflow efficiency tools for pathologists. The platform is designed to improve diagnostic accuracy and speed up the pathology review process.
In November 2021, Roche announced that it had received clearance from the U.S. Food and Drug Administration (FDA) for its VENTANA DP 200 slide scanner, which is used for digital pathology applications. The clearance allows Roche to market the scanner in the United States for clinical diagnostic purposes.
1. Global Digital Pathology Market Introduction and Market Overview
1.1. Objective of the Market Research Study
1.2. Digital Pathology Market Definition & Description
1.3. Research Data Parameters & Reporting Timelines
1.3.1. Historical Data Reporting Years 2020 to 2021
1.3.2. Projected Data Reporting Years 2022 to 2033
1.3.3. Reporting Data Parameters Value (US$ Million)
1.4. Global Digital Pathology Market Scope and Market Estimation
1.4.1. Global Digital Pathology Overall Market Size (US$ Million), Market CAGR (%), Market Estimates & Forecast (2020 to 2033)
1.4.2. Global Digital Pathology Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2020 to 2033
1.5. Digital Pathology Market Segmentation
1.5.1. Product of Global Digital Pathology Market
1.5.2. Type of Global Digital Pathology Market
1.5.3. Application of Global Digital Pathology Market
1.5.4. End Users of Digital Pathology Market
1.5.5. Key Regions of Digital Pathology Market
2. Global Digital Pathology Market - Executive Summary
2.1. Global Digital Pathology Market Summary & Snapshot
2.2. Global Digital Pathology Market, By Product (US$ Million)
2.3. Global Digital Pathology Market, By Type (US$ Million)
2.4. Global Digital Pathology Market, By Application (US$ Million)
2.5. Global Digital Pathology Market, End Users (US$ Million)
2.6. Global Digital Pathology Market, By Geography (US$ Million)
2.7. Global Digital Pathology Market Outlook & Future Opportunities
3. Digital Pathology Market Trends, Outlook, and Factors Analysis
3.1. Global Digital Pathology Market Industry Development Trends under COVID-19 Outbreak
3.1.1. Global COVID-19 Status Overview
3.1.2. Influence of COVID-19 Outbreak on Global Digital Pathology Market Industry Development
3.1.3. Pre & Post COVID-19 Trends and Scenarios
3.2. Digital Pathology Market Dynamics (Growth Impacting Factors & Rationales)
3.2.1. Drivers
3.2.1.1. Digital pathology helps in reducing overall cost, reduced turnaround time, and direct contact with industry experts.
3.2.2. Restraints
3.2.2.1. digital pathology systems are typically too expensive to be owned by small and medium capital ventures, thou the big ones can afford but they all do not want to invest this amount into one system.
3.2.3. Opportunities
3.2.3.1. Development of affordable equipment for Digital pathology through research and development to replace current and operating systems.
3.2.4. Impact Analysis of Drivers and Restraints
3.3. Ecosystem/ Value Chain Analysis
3.4. Porters Five Forces Analysis
3.5. SWOT Analysis
3.6. PEST Analysis
3.7. Average Selling Prices and Pricing Trends Analysis of Digital Pathology Market
3.8. Technological Roadmap
3.9. Key Investment Pockets of Digital Pathology Market
3.9.1. By Product
3.9.2. By Type
3.9.3. By Application
3.9.4. By End Users
3.9.5. By Regions
4. Global Digital Pathology Market: Estimates & Historic Trend Analysis (2020 to 2021)
4.1. Global Digital Pathology Market, 2020 2021 (US$ Million)
4.2. Global Digital Pathology Market, By Product, 2020 To 2021 (US$ Million)
4.3. Global Digital Pathology Market, By Type, 2020 To 2021 (US$ Million)
4.4. Global Digital Pathology Market, By Application, 2020 To 2021 (US$ Million)
4.5. Global Digital Pathology Market, By End Users, 2020 To 2021 (US$ Million)
4.6. Global Digital Pathology Market, By Region, 2020 To 2021 (US$ Million)
5. Global Digital Pathology Market Estimates & Forecast Trend Analysis, by Product
5.1. Global Digital Pathology Market Share (%) Estimates and Forecasts, by Product, 2022 & 2033
5.2. Global Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts, by Product, 2022 to 2033
5.2.1. Scanners
5.2.1.1. Brightfield
5.2.1.2. Other Scanners
5.2.2. Software
5.2.2.1. Integrated Software
5.2.2.2. Standalone Software
5.2.2.3. Information Management Software
5.2.2.4. Image Analysis Software
5.2.3. Storage Systems
6. Global Digital Pathology Market Estimates & Forecast Trend Analysis, by Type
6.1. Global Digital Pathology Market Share (%) Estimates and Forecasts, By Type, 2022 & 2033
6.2. Global Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts, by Type, 2022 to 2033
6.2.1. Human Pathology
6.2.2. Veterinary Pathology
7. Global Digital Pathology Market Estimates & Forecast Trend Analysis, by Application
7.1. Global Digital Pathology Market Share (%) Estimates and Forecasts, By Application, 2022 & 2033
7.2. Global Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts, by Application, 2022 to 2033
7.2.1. Drug Discovery
7.2.2. Disease Diagnosis
7.2.3. Training & Education
7.2.4. Teleconsultation
8. Global Digital Pathology Market Estimates & Forecast Trend Analysis, by End Users
8.1. Global Digital Pathology Market Share (%) Estimates and Forecasts, By End Users, 2022 & 2033
8.2. Global Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts, by End Users, 2022 to 2033
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Hospitals and Reference Laboratories
8.2.3. Academic & Research Institutes
9. Global Digital Pathology Market Analysis and Forecast, by Region
9.1. Global Digital Pathology Market Share (%) Estimates and Forecasts, By Region, 2022 & 2033
9.2. Global Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts, By Region, 2022 To 2033
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Middle East and Africa
9.2.5. Latin America
10. North America Digital Pathology Market: Estimates & Forecast Trend Analysis
10.1. North America Digital Pathology Market Assessments & Key Findings
10.2. North America Digital Pathology Market Share (%) Estimates and Forecasts, 2022 & 2033
10.3. North America Digital Pathology Market Size Estimates and Forecast (US$ Million) (2022 To 2033)
10.3.1. By Product
10.3.2. By Type
10.3.3. By Application
10.3.4. By End Users
10.3.5. By Major Country
10.3.5.1. The U.S.
10.3.5.2. Canada
11. Europe Digital Pathology Market: Estimates & Forecast Trend Analysis
11.1. Europe Digital Pathology Market Assessments & Key Findings
11.2. Europe Digital Pathology Market Share (%) Estimates and Forecasts, 2022 & 2033
11.3. Europe Digital Pathology Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
11.3.1. By Product
11.3.2. By Type
11.3.3. By Application
11.3.4. By End Users
11.3.5. By Major Country
11.3.5.1. Germany
11.3.5.2. The U.K.
11.3.5.3. France
11.3.5.4. Italy
11.3.5.5. Spain
11.3.5.6. Rest of Europe (includes all other European countries)
12. Asia Pacific Digital Pathology Market: Estimates & Forecast Trend Analysis
12.1. Asia Pacific Digital Pathology Market Assessments & Key Findings
12.2. Asia Pacific Digital Pathology Market Share (%) Estimates and Forecasts, 2022 & 2033
12.3. Asia Pacific Digital Pathology Market Size Estimates and Forecast (US$ Million) (2022 To 2033)
12.3.1. By Product
12.3.2. By Type
12.3.3. By Application
12.3.4. By End Users
12.3.5. By Major Country
12.3.5.1. China
12.3.5.2. Japan
12.3.5.3. India
12.3.5.4. ASEAN
12.3.5.5. South Korea
12.3.5.6. Rest of Asia Pacific (includes all other Asia Pacific countries)
13. Middle East & Africa Digital Pathology Market: Estimates & Forecast Trend Analysis
13.1. Middle East & Africa Digital Pathology Market Assessments & Key Findings
13.2. Middle East & Africa Digital Pathology Market Share (%) Estimates and Forecasts, 2022 & 2033
13.3. Middle East & Africa Digital Pathology Market Size Estimates and Forecast (US$ Million) (2022 To 2033)
13.3.1. By Product
13.3.2. By Type
13.3.3. By Application
13.3.4. By End Users
13.3.5. By Major Country
13.3.5.1. GCC
13.3.5.2. South Africa
13.3.5.3. Egypt
13.3.5.4. Rest of Middle East & Africa (includes all other Middle East & Africa countries)
14. Latin America Digital Pathology Market: Estimates & Forecast Trend Analysis
14.1. Latin America Market Assessments & Key Findings
14.2. Latin America Digital Pathology Market Share (%) Estimates and Forecasts, 2022 & 2033
14.3. Latin America Digital Pathology Market Size Estimates and Forecast (US$ Million) (2022 to 2033)
14.3.1. By Product
14.3.2. By Type
14.3.3. By Application
14.3.4. By End Users
14.3.5. By Major Country
14.3.5.1. Brazil
14.3.5.2. Mexico
14.3.5.3. Rest of Latin America (includes all other Latin America countries)
15. Competitive Landscape
15.1. Digital Pathology Market Revenue Share Analysis (%), By Major Players (2021)
15.2. Digital Pathology Market Competition Matrix, By Leading Players
15.3. Digital Pathology List of Emerging, Prominent and Leading Players
15.4. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Recent Developments, Etc.
16. Company Profiles
16.1. Biosystems
16.1.1. Company Overview & Insights
16.1.2. Financial Performance
16.1.3. Product / Service Portfolio
16.1.4. Geographical Footprint & Share
16.1.5. Strategic Initiatives & Key Developments
*Similar details would be provided for all the players mentioned below
16.2. Leica Biosystems
16.3. Koninklijke Philips N.V.
16.4. Hamamatsu Photonics
16.5. F. Hoffmann-La Roche Ltd.
16.6. 3DHISTECH (Hungary)
16.7. Apollo Enterprise Imaging
16.8. XIFIN, Inc
16.9. Huron Digital Pathology
16.10. Visiopharm A/S
16.11. Aiforia Technologies Oy
16.12. Akoya Biosciences
16.13. Corista
16.14. Indica Labs
16.15. Objective Pathology Services
16.16. Sectra AB
16.17. OptraSCAN
16.18. Glencoe Software
16.19. KONFOONG BIOTECH INTERNATIONAL CO., LTD
16.20. Inspirata, Inc.
16.21. PathAI
16.22. Proscia Inc.
16.23. Kanteron Systems
16.24. Mikroscan Technologies
16.25. Motic
16.26. Paige
16.27. Others
17. Assumptions and Research Methodology
17.1. Data Mining
17.2. Secondary Research
17.3. Primary Research
17.4. Subject Matter Expert Advice
17.5. Quality Check
17.6. Final Review
17.7. Data Triangulation
17.8. Bottom-Up Approach
17.9. Top Down Approach
17.10. Research Flow
17.11. Key Insights from Industry Experts
17.12. Data Products
17.13. Assumptions
17.14. Limitations
18. Conclusions and Recommendations
18.1. Key Research Findings and Conclusion
18.2. Key Insights & Recommendations from Analysts